Mjn-neuro (private company)

See something wrong or missing? Let us know
Offices:Girona
Business model:B2B

Mjn-neuro is specialized in developing medical solutions to predict epileptic seizures and seeks to adapt its knowledge to also advance against Alzheimer's.

Investors: we tracked 2 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Mjn-neuro

Name Criteria
Denmark Bainan Biotech
55%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one other investor: found 1
Denmark Biograil
55%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one other investor: found 2
Switzerland Bionomous
55%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one other investor: found 1
Germany CatalYm
55%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one other investor: found 2
Spain Cebiotex
55%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one other investor: found 1
France Cell-Easy
55%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one other investor: found 2
Sweden Celluminova
55%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one other investor: found 2
Spain Cornea Project
55%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one other investor: found 1
France InnovaFeed SAS
55%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one other investor: found 2
Switzerland Memo Therapeutics
55%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one other investor: found 2
Top